Vasculitis: Inflammation of Blood Vessel Walls
Vasculitis encompasses a group of autoimmune disorders characterized by inflammation of blood vessel walls, leading to organ damage through ischemia and hemorrhage. Environmental chemical exposures that activate vascular endothelial cells and immune effectors may contribute to vasculitis onset or flares in susceptible individuals.
PFAS and Vascular Endothelial Immune Activation
PFAS directly activate vascular endothelial cells, inducing expression of adhesion molecules (ICAM-1, VCAM-1) and pro-inflammatory cytokines that recruit immune cells to vessel walls. This endothelial activation pattern parallels the initial steps in vasculitis pathogenesis, suggesting PFAS as potential environmental triggers for vascular inflammatory disease.
ANCA-Associated Vasculitis Connections
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis—including granulomatosis with polyangiitis—involves ANCA-mediated neutrophil activation against vascular walls. PFAS compounds promote neutrophil reactive oxygen species production and prime neutrophils for ANCA-mediated vascular damage, potentially lowering the threshold for clinically apparent vasculitis in ANCA-positive individuals.
Clinical Rheumatology Considerations
Rheumatologists evaluating vasculitis—particularly in atypical presentations or patients from PFAS-contaminated communities—should document environmental exposure history. PFAS body burden testing in vasculitis patients with exposures at contamination sites may provide insights into environmental contributors and guide exposure reduction as an adjunct to immunosuppressive therapy